HealthFinSMEsabout 1 hour ago
Caravel Bio Wins $1.2M NSF Grant
1 min read
Caravel Bio, a Portland, OR-based biomolecular engineering provider, received a $1.2M NSF Phase II Grant on 03/11/2026. The company plans to use funds for developing protein systems with new chemistries, scaling machine learning datasets, and executing pilots in DNA writing and carbon capture.
Level
Hype check
Tap to vote and see what everyone thinks.